China Regenerative Medicine International Limited (8158.HK)

0.185 +0.003 (+1.65%) At close: 03:18PM HKT

China Regenerative Medicine International Limited

Miramar Tower
Suite 2310–18 132 Nathan Road
Tsim Sha Tsui
Hong Kong
852 3918 9005
https://www.crmi.hk

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 46

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Chuang Wang	CEO, Executive Chairman & Compliance Officer	1.2M	N/A	1979
Mr. Po Tin Wong	Chief Financial Officer	N/A	N/A	N/A
Dr. Xiaohu Sun	Chief Operating Officer	N/A	N/A	1965
Dr. Jinnan Zhang	Chief Technology Officer	N/A	N/A	1985
Mr. Wing Nin Ip	Legal Counsel	N/A	N/A	N/A
Dr. Zhanfeng Cui Freng	Chairman of Stem Cell Division & Director of University of Oxford Tissue Engineering Centre	500k	N/A	1963
Mr. Wun Fat Khoo	Company Secretary	N/A	N/A	1981

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People's Republic of China. The company offers various health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services, including non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate rejuvenation treatment services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.

Corporate Governance

China Regenerative Medicine International Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.